Article Versions Notes

Solignac J, Dou L, Chermiti R, McKay N, Giaime P, Pedinielli N, Benjelloun H, Lano G, Mancini J, Burtey S, et al. Myostatin Exacerbates Endothelial Dysfunction Induced by Uremic Toxin Indoxyl Sulfate and Is Associated with Hemodialysis Arteriovenous Access Complications. Toxins. 2025; 17(4):159. https://doi.org/10.3390/toxins17040159

Solignac, Justine, Laetitia Dou, Rania Chermiti, Nathalie McKay, Philippe Giaime, Nathalie Pedinielli, Hamza Benjelloun, Guillaume Lano, Julien Mancini, Stéphane Burtey, and et al. 2025. "Myostatin Exacerbates Endothelial Dysfunction Induced by Uremic Toxin Indoxyl Sulfate and Is Associated with Hemodialysis Arteriovenous Access Complications" Toxins 17, no. 4: 159. https://doi.org/10.3390/toxins17040159

Solignac, J., Dou, L., Chermiti, R., McKay, N., Giaime, P., Pedinielli, N., Benjelloun, H., Lano, G., Mancini, J., Burtey, S., & Bataille, S. (2025). Myostatin Exacerbates Endothelial Dysfunction Induced by Uremic Toxin Indoxyl Sulfate and Is Associated with Hemodialysis Arteriovenous Access Complications. Toxins, 17(4), 159. https://doi.org/10.3390/toxins17040159